女性慢阻肺患者一年内死亡风险预测模型的开发与验证
研究基于澳大利亚女性健康纵向研究1921-1926队列中1236例慢阻肺女性数据,开发并验证用于识别临终前一年需姑息治疗的风险预测模型。模型含六个预测因子,AUROC为0.82(95%CI:0.80-0.85),校准良好,决策曲线分析显示临床净获益。
要点
- 模型含吸烟状态、BMI、日常活动需regular assistance、供药数量、病程、住院次数六个预测因子。
- 以56.6%预测风险为切点,灵敏度72.3%、特异度77.7%、准确率75.0%。
- 模型预测性能良好且易于应用,但需外部验证。
核心结论
- 该风险预测模型能稳健识别可能受益于姑息治疗的女性慢阻肺患者,但需外部验证。
研究设计与样本
- 研究分析澳大利亚女性健康纵向研究1921-1926队列中1236例确诊慢阻肺的女性数据,并链接行政健康记录。
- 采用Lasso回归和多变量logistic回归筛选预测因子,以AUROC、校准图和校准指标评估预测性能。
主要发现
- 最终预测1年全因死亡的模型含六个预测因子:吸烟状态、体重指数、日常活动需定期协助、供药数量、病程和住院次数。
- 模型AUROC为0.82(95%CI:0.80-0.85),校准表现优秀。
- 以56.6%预测风险为切点,模型灵敏度72.3%、特异度77.7%、准确率75.0%。
- 决策曲线分析表明模型为临床决策提供更大净获益。
关键数值与推荐
- 预测1年全因死亡风险模型包含六个预测因子:吸烟状态、体重指数、日常活动需定期协助、供药数量、病程、住院次数。
- 模型AUROC为0.82(95%CI:0.80-0.85)。
- 风险分类最佳切点为56.6%预测风险,对应灵敏度72.3%、特异度77.7%、准确率75.0%。
临床怎么用
- 该模型可帮助临床医生识别女性慢阻肺患者中可能受益于姑息治疗的高风险个体,促进及时转诊和干预。
局限性
- 模型需要外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Proactive palliative interventions can improve symptom control and quality of life in individuals with chronic obstructive pulmonary disease (COPD); however, they are often underutilised. This study aimed to develop and validate a prediction model to identify women with COPD in their last year of life to facilitate timely palliative care referrals and interventions. METHODS: Data from 1236 women diagnosed with COPD from the 1921-1926 Australian Longitudinal Study on Women's Health cohort, linked to administrative health records, were analysed. We employed Lasso regression and multivariable logistic regression to select predictors. To assess the predictive performance of the model, we used the area under the receiver operating characteristic (AUROC) curve, calibration plot, and calibration metrics. The Youden index was used to establish the optimal cutoff point for risk classification. The clinical utility of the model was evaluated using decision curve analysis (DCA). RESULTS: The final model to predict 1-year all-cause mortality included six predictors: smoking status, body mass index, needing regular assistance with daily activities, number of supplied medications, duration of illness, and number of hospital admissions. The model performed well, with AUROC of 0.82 (95% CI: 0.80-0.85) and showed excellent calibration. Using a cutoff of 56.6% predicted risk, the model achieved a sensitivity of 72.3%, specificity of 77.7%, and accuracy of 75.0%. The DCA indicated that the model provided a greater net benefit for clinical decision-making. CONCLUSION: Our prediction model for identifying women with COPD who may benefit from palliative care has shown robust predictive performance and can be easily applied, but requires external validation.
引用
- Gebresillassie BM, Attia J, Cavenagh D, et al. Development and Validation of a Risk Prediction Model to Identify Women With Chronic Obstructive Pulmonary Disease for Proactive Palliative Care. Respirology. 2025. PMID: 39956990. doi:10.1111/resp.70005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。